These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 36774237)
1. Lymphomas in patients with neurofibromatosis type 1 (NF1): another malignancy in the NF1 syndrome? Fareez F; Wang BH; Brain I; Lu JQ Pathology; 2023 Apr; 55(3):302-314. PubMed ID: 36774237 [TBL] [Abstract][Full Text] [Related]
2. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Ratner N; Miller SJ Nat Rev Cancer; 2015 May; 15(5):290-301. PubMed ID: 25877329 [TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis type 1: Fundamental insights into cell signalling and cancer. Rad E; Tee AR Semin Cell Dev Biol; 2016 Apr; 52():39-46. PubMed ID: 26860753 [TBL] [Abstract][Full Text] [Related]
4. Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease. Abramowicz A; Gos M Dev Period Med; 2014; 18(3):297-306. PubMed ID: 25182393 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous neurofibromas in the genomics era: current understanding and open questions. Allaway RJ; Gosline SJC; La Rosa S; Knight P; Bakker A; Guinney J; Le LQ Br J Cancer; 2018 Jun; 118(12):1539-1548. PubMed ID: 29695767 [TBL] [Abstract][Full Text] [Related]
7. A porcine model of neurofibromatosis type 1 that mimics the human disease. White KA; Swier VJ; Cain JT; Kohlmeyer JL; Meyerholz DK; Tanas MR; Uthoff J; Hammond E; Li H; Rohret FA; Goeken A; Chan CH; Leidinger MR; Umesalma S; Wallace MR; Dodd RD; Panzer K; Tang AH; Darbro BW; Moutal A; Cai S; Li W; Bellampalli SS; Khanna R; Rogers CS; Sieren JC; Quelle DE; Weimer JM JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925695 [TBL] [Abstract][Full Text] [Related]
9. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448 [TBL] [Abstract][Full Text] [Related]
10. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1. Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990 [TBL] [Abstract][Full Text] [Related]
11. The NF1 gene in tumor syndromes and melanoma. Kiuru M; Busam KJ Lab Invest; 2017 Feb; 97(2):146-157. PubMed ID: 28067895 [TBL] [Abstract][Full Text] [Related]
12. Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations? Alkindy A; Chuzhanova N; Kini U; Cooper DN; Upadhyaya M Hum Genomics; 2012 Aug; 6(1):12. PubMed ID: 23244495 [TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas. Helfferich J; Nijmeijer R; Brouwer OF; Boon M; Fock A; Hoving EW; Meijer L; den Dunnen WF; de Bont ES Crit Rev Oncol Hematol; 2016 Aug; 104():30-41. PubMed ID: 27263935 [TBL] [Abstract][Full Text] [Related]
14. Neurofibromin and suppression of tumorigenesis: beyond the GAP. Mo J; Moye SL; McKay RM; Le LQ Oncogene; 2022 Feb; 41(9):1235-1251. PubMed ID: 35066574 [TBL] [Abstract][Full Text] [Related]
15. The NF1 somatic mutational landscape in sporadic human cancers. Philpott C; Tovell H; Frayling IM; Cooper DN; Upadhyaya M Hum Genomics; 2017 Jun; 11(1):13. PubMed ID: 28637487 [TBL] [Abstract][Full Text] [Related]
16. Novel and Recurring Disease-Causing NF1 Variants in Two Chinese Families with Neurofibromatosis Type 1. Xiao H; Yuan L; Xu H; Yang Z; Huang F; Song Z; Yang Y; Zeng C; Deng H J Mol Neurosci; 2018 Aug; 65(4):557-563. PubMed ID: 30046999 [TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications. Gottfried ON; Viskochil DH; Couldwell WT Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723 [TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2. Patrakitkomjorn S; Kobayashi D; Morikawa T; Wilson MM; Tsubota N; Irie A; Ozawa T; Aoki M; Arimura N; Kaibuchi K; Saya H; Araki N J Biol Chem; 2008 Apr; 283(14):9399-413. PubMed ID: 18218617 [TBL] [Abstract][Full Text] [Related]
19. [Neurofibromatosis von Recklinghausen type 1 (NF1) - clinical picture and molecular-genetics diagnostic]. Petrák B; Bendová Š; Lisý J; Kraus J; Zatrapa T; Glombová M; Zámečník J Cesk Patol; 2015; 51(1):34-40. PubMed ID: 25671360 [TBL] [Abstract][Full Text] [Related]
20. Advanced pharmacological therapies for neurofibromatosis type 1-related tumors. Foiadelli T; Naso M; Licari A; Orsini A; Magistrali M; Trabatti C; Luzzi S; Mosconi M; Savasta S; Marseglia GL Acta Biomed; 2020 Jun; 91(7-S):101-114. PubMed ID: 32608378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]